BBSRC Portfolio Analyser
BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments:
UKRI - What we have funded
Investigator / Supervisor details
Name
Dr Mark Tricklebank
Current Institution
Eli Lilly and Company Limited
Current Department
Basingstoke
Previous Institutions
Current Awards
No current BBSRC awards
Completed Awards
Reference
Title
Award Role
Value £
Type
BB/I016368/1
Metabotropic glutamate receptor regulation of cardiovascular activity in conscious rats
Co-investigator
91,932
Training Grants
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search